Tech Company Financing Transactions
VERIGRAFT Funding Round
VERIGRAFT closed a $1.3 million funding round on 2/14/2025. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/14/2025
Transaction Type
Venture Equity
Amount
$1,250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Arvid Wallgrens Backe 20
Gothenburg, 41346
Sweden
Gothenburg, 41346
Sweden
Phone
Undisclosed
Website
Email Address
Overview
VERIGRAFT is a biotechnology company based in Gothenburg, Sweden. The company is rooted in the Karolinska Institute, based on groundbreaking basic science with a focus on regenerative medicine since 2014. VERIGRAFT has grown to become a forerunner in industrialized tissue engineering and advanced regenerative medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jan Holgersson
Chief Executive Officer
Petter Bjorquist
Chief Financial Officer
Edward Nordfors
Chief Technical Officer
Raimund Strehl
Browse more venture capital transactions:
Prev: 2/14/2025: Apptronik venture capital transaction
Next: 2/14/2025: AudioCure Pharma venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs